NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|308522730|ref|NP_001184163|]
View 

butyrophilin subfamily 2 member A1 isoform 4 precursor [Homo sapiens]

Protein Classification

Ig_MOG_like domain-containing protein( domain architecture ID 10145916)

Ig_MOG_like domain-containing protein

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
IgV_MOG_like cd05713
Immunoglobulin (Ig)-like domain of myelin oligodendrocyte glycoprotein (MOG); The members here ...
30-143 4.78e-68

Immunoglobulin (Ig)-like domain of myelin oligodendrocyte glycoprotein (MOG); The members here are composed of the immunoglobulin (Ig)-like domain of myelin oligodendrocyte glycoprotein (MOG). MOG, a minor component of the myelin sheath, is an important CNS-specific autoantigen, linked to the pathogenesis of multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE). It is a transmembrane protein having an extracellular Ig domain. MOG is expressed in the CNS on the outermost lamellae of the myelin sheath, and on the surface of oligodendrocytes, and may participate in the completion, compaction, and/or maintenance of myelin. This group also includes butyrophilin (BTN). BTN is the most abundant protein in bovine milk-fat globule membrane (MFGM).


:

Pssm-ID: 409378  Cd Length: 114  Bit Score: 208.20  E-value: 4.78e-68
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 308522730  30 FIVVGPTDPILATVGENTTLRCHLSPEKNAEDMEVRWFRSQFSPAVFVYKGGRERTEEQMEEYRGRTTFVSKDISRGSVA 109
Cdd:cd05713    1 FSVIGPTEPILALVGEDAELPCHLSPKMSAEHMEVRWFRSQFSPVVHLYRDGQDQEEEQMPEYRGRTELLKDAIAEGSVA 80
                         90       100       110
                 ....*....|....*....|....*....|....
gi 308522730 110 LVIHNITAQENGTYRCYFQEGRSYDEAILHLVVA 143
Cdd:cd05713   81 LRIHNVRPSDEGQYTCFFRSGSFYEEATLELKVA 114
PRK12704 super family cl36166
phosphodiesterase; Provisional
251-322 2.77e-03

phosphodiesterase; Provisional


The actual alignment was detected with superfamily member PRK12704:

Pssm-ID: 237177 [Multi-domain]  Cd Length: 520  Bit Score: 39.38  E-value: 2.77e-03
                         10        20        30        40        50        60        70
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 308522730 251 LPIIVVILMIPIAVCI-YWINKLQKEKKILSGEKEFER--ETREIALKELEKERV--QKEEELQVKEKLQEELRWRR 322
Cdd:PRK12704   5 IIILIALVALVVGAVIgYFVRKKIAEAKIKEAEEEAKRilEEAKKEAEAIKKEALleAKEEIHKLRNEFEKELRERR 81
 
Name Accession Description Interval E-value
IgV_MOG_like cd05713
Immunoglobulin (Ig)-like domain of myelin oligodendrocyte glycoprotein (MOG); The members here ...
30-143 4.78e-68

Immunoglobulin (Ig)-like domain of myelin oligodendrocyte glycoprotein (MOG); The members here are composed of the immunoglobulin (Ig)-like domain of myelin oligodendrocyte glycoprotein (MOG). MOG, a minor component of the myelin sheath, is an important CNS-specific autoantigen, linked to the pathogenesis of multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE). It is a transmembrane protein having an extracellular Ig domain. MOG is expressed in the CNS on the outermost lamellae of the myelin sheath, and on the surface of oligodendrocytes, and may participate in the completion, compaction, and/or maintenance of myelin. This group also includes butyrophilin (BTN). BTN is the most abundant protein in bovine milk-fat globule membrane (MFGM).


Pssm-ID: 409378  Cd Length: 114  Bit Score: 208.20  E-value: 4.78e-68
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 308522730  30 FIVVGPTDPILATVGENTTLRCHLSPEKNAEDMEVRWFRSQFSPAVFVYKGGRERTEEQMEEYRGRTTFVSKDISRGSVA 109
Cdd:cd05713    1 FSVIGPTEPILALVGEDAELPCHLSPKMSAEHMEVRWFRSQFSPVVHLYRDGQDQEEEQMPEYRGRTELLKDAIAEGSVA 80
                         90       100       110
                 ....*....|....*....|....*....|....
gi 308522730 110 LVIHNITAQENGTYRCYFQEGRSYDEAILHLVVA 143
Cdd:cd05713   81 LRIHNVRPSDEGQYTCFFRSGSFYEEATLELKVA 114
V-set pfam07686
Immunoglobulin V-set domain; This domain is found in antibodies as well as neural protein P0 ...
38-142 8.10e-12

Immunoglobulin V-set domain; This domain is found in antibodies as well as neural protein P0 and CTL4 amongst others.


Pssm-ID: 462230  Cd Length: 109  Bit Score: 61.32  E-value: 8.10e-12
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 308522730   38 PILATVGENTTLRCHLSPEKNAEDMEVRWFR----SQFSPAVFVYKGGRerteeQMEEYRGRTTFvSKDISRGSVALVIH 113
Cdd:pfam07686   5 EVTVALGGSVTLPCTYSSSMSEASTSVYWYRqppgKGPTFLIAYYSNGS-----EEGVKKGRFSG-RGDPSNGDGSLTIQ 78
                          90       100       110
                  ....*....|....*....|....*....|
gi 308522730  114 NITAQENGTYRCY-FQEGRSYDEAILHLVV 142
Cdd:pfam07686  79 NLTLSDSGTYTCAvIPSGEGVFGKGTRLTV 108
IGv smart00406
Immunoglobulin V-Type;
48-125 3.02e-10

Immunoglobulin V-Type;


Pssm-ID: 214650  Cd Length: 81  Bit Score: 55.85  E-value: 3.02e-10
                           10        20        30        40        50        60        70
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 308522730    48 TLRCHLSPEKNAeDMEVRWFR-SQFSPAVFVYKGGRERTEEQMEEYRGRTTFvSKDISRGSVALVIHNITAQENGTYRC 125
Cdd:smart00406   3 TLSCKFSGSTFS-SYYVSWVRqPPGKGLEWLGYIGSNGSSYYQESYKGRFTI-SKDTSKNDVSLTISNLRVEDTGTYYC 79
PRK12704 PRK12704
phosphodiesterase; Provisional
251-322 2.77e-03

phosphodiesterase; Provisional


Pssm-ID: 237177 [Multi-domain]  Cd Length: 520  Bit Score: 39.38  E-value: 2.77e-03
                         10        20        30        40        50        60        70
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 308522730 251 LPIIVVILMIPIAVCI-YWINKLQKEKKILSGEKEFER--ETREIALKELEKERV--QKEEELQVKEKLQEELRWRR 322
Cdd:PRK12704   5 IIILIALVALVVGAVIgYFVRKKIAEAKIKEAEEEAKRilEEAKKEAEAIKKEALleAKEEIHKLRNEFEKELRERR 81
PilN COG3166
Type IV pilus assembly protein PilN [Cell motility, Extracellular structures];
249-317 9.85e-03

Type IV pilus assembly protein PilN [Cell motility, Extracellular structures];


Pssm-ID: 442399 [Multi-domain]  Cd Length: 185  Bit Score: 36.48  E-value: 9.85e-03
                         10        20        30        40        50        60        70
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 308522730 249 VALPIIVVILMIPIAVCIYW-----INKLQKEKKILSGE-KEFERETREIalKELEKERVQKEEELQVKEKLQEE 317
Cdd:COG3166   22 LALLVLALLLALAVLFLVYLylqgqIAQQQARNAALQQEiAKLDKQIAEI--KELKKQKAELLARLQVIEQLQQS 94
 
Name Accession Description Interval E-value
IgV_MOG_like cd05713
Immunoglobulin (Ig)-like domain of myelin oligodendrocyte glycoprotein (MOG); The members here ...
30-143 4.78e-68

Immunoglobulin (Ig)-like domain of myelin oligodendrocyte glycoprotein (MOG); The members here are composed of the immunoglobulin (Ig)-like domain of myelin oligodendrocyte glycoprotein (MOG). MOG, a minor component of the myelin sheath, is an important CNS-specific autoantigen, linked to the pathogenesis of multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE). It is a transmembrane protein having an extracellular Ig domain. MOG is expressed in the CNS on the outermost lamellae of the myelin sheath, and on the surface of oligodendrocytes, and may participate in the completion, compaction, and/or maintenance of myelin. This group also includes butyrophilin (BTN). BTN is the most abundant protein in bovine milk-fat globule membrane (MFGM).


Pssm-ID: 409378  Cd Length: 114  Bit Score: 208.20  E-value: 4.78e-68
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 308522730  30 FIVVGPTDPILATVGENTTLRCHLSPEKNAEDMEVRWFRSQFSPAVFVYKGGRERTEEQMEEYRGRTTFVSKDISRGSVA 109
Cdd:cd05713    1 FSVIGPTEPILALVGEDAELPCHLSPKMSAEHMEVRWFRSQFSPVVHLYRDGQDQEEEQMPEYRGRTELLKDAIAEGSVA 80
                         90       100       110
                 ....*....|....*....|....*....|....
gi 308522730 110 LVIHNITAQENGTYRCYFQEGRSYDEAILHLVVA 143
Cdd:cd05713   81 LRIHNVRPSDEGQYTCFFRSGSFYEEATLELKVA 114
IgV_B7-H4 cd20984
Immunoglobulin Variable (IgV) domain of B7-H4; The members here are composed of the ...
40-126 5.49e-14

Immunoglobulin Variable (IgV) domain of B7-H4; The members here are composed of the immunoglobulin variable (IgV) domain of B7-H4 (also known as B7-S1, B7x, or Vtcn1). B7-H4 is one of the B7 family of immune-regulatory ligands that act as negative regulators of T cell function; it contains one IgV domain and one IgC domain. The B7-family consists of structurally related cell-surface protein ligands, which bind to receptors on lymphocytes that regulate immune responses. The binding of B7-H4 to unidentified receptors results in the inhibition of TCR-mediated T cell proliferation, cell-cycle progression and IL-2 production. As a co-inhibitory molecule, B7-H4 is widely expressed in tumor tissues and its expression is significantly associated with poor prognosis in human cancers such as glioma, pancreatic cancer, oral squamous cell carcinoma, renal cell carcinoma, and lung cancer.


Pssm-ID: 409576  Cd Length: 110  Bit Score: 67.24  E-value: 5.49e-14
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 308522730  40 LATVGENTTLRCHLSPEKNAEDMEVRWFRSQFSPAVFVYKGGRERTEEQMEEYRGRTTFVSKDISRGSVALVIHNITAQE 119
Cdd:cd20984    8 AGNIGEDGILSCTFTPDIKLSDIVIQWLKEGDSGLVHEFKEGKDELSRQSPMFRGRTSLFADQVHVGNASLRLKNVQLTD 87

                 ....*..
gi 308522730 120 NGTYRCY 126
Cdd:cd20984   88 AGTYLCI 94
V-set pfam07686
Immunoglobulin V-set domain; This domain is found in antibodies as well as neural protein P0 ...
38-142 8.10e-12

Immunoglobulin V-set domain; This domain is found in antibodies as well as neural protein P0 and CTL4 amongst others.


Pssm-ID: 462230  Cd Length: 109  Bit Score: 61.32  E-value: 8.10e-12
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 308522730   38 PILATVGENTTLRCHLSPEKNAEDMEVRWFR----SQFSPAVFVYKGGRerteeQMEEYRGRTTFvSKDISRGSVALVIH 113
Cdd:pfam07686   5 EVTVALGGSVTLPCTYSSSMSEASTSVYWYRqppgKGPTFLIAYYSNGS-----EEGVKKGRFSG-RGDPSNGDGSLTIQ 78
                          90       100       110
                  ....*....|....*....|....*....|
gi 308522730  114 NITAQENGTYRCY-FQEGRSYDEAILHLVV 142
Cdd:pfam07686  79 NLTLSDSGTYTCAvIPSGEGVFGKGTRLTV 108
IgV_B7-H3 cd20934
Immunoglobulin Variable (IgV) domain of B7-H3, a member of the B7 family of immune checkpoint ...
35-143 1.09e-11

Immunoglobulin Variable (IgV) domain of B7-H3, a member of the B7 family of immune checkpoint molecules; The members here are composed of the immunoglobulin variable (IgV) domain of B7-H3 also known as CD276), a member of the B7 family of immune checkpoint molecules. B7-H3 is an important immune checkpoint member of the B7 family and shares homology with other B7 ligands such as programmed death ligand 1 (PD-L1). The B7 family molecules interact with CD28 on T-cells to provide co-stimulatory signals that regulate T-cell activation and T-helper cell differentiation. Although B7-H3 has been shown to have both co-stimulatory and co-inhibitory effects on T-cell responses, the most current studies describe B7-H3 as a T cell inhibitor that promotes tumor aggressiveness and proliferation. Moreover, B7-H3 is highly overexpressed on a wide range of human solid cancers and promotes tumor growth, metastasis, and drug resistance. Thus, B7-H3 expression in tumors often correlates with both negative prognosis and poor clinical outcome in cancer patients. B7-H3 protein contains a predicted signal peptide, V- and C-like Ig domains (IgV and IgC), a transmembrane region, and an intracellular tail.


Pssm-ID: 409528  Cd Length: 115  Bit Score: 61.08  E-value: 1.09e-11
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 308522730  35 PTDPILATVGENTTLRCHLSPEK--NAEDMEVRWFRSQFSPAVFVYKGGRERTEEQMEEYRGRTTFVSKDISRGSVALVI 112
Cdd:cd20934    3 PEDPVVALVGTDATLRCSFSPEPgfSLAQLSVFWQLTDTKQLVHSFTESQDQGRDQGSAYANRTALFPDLLAQGNASLRL 82
                         90       100       110
                 ....*....|....*....|....*....|.
gi 308522730 113 HNITAQENGTYRCyFQEGRSYDEAILHLVVA 143
Cdd:cd20934   83 QRVRVADEGSYTC-FVSVQDFGSAAVSLQVA 112
IGv smart00406
Immunoglobulin V-Type;
48-125 3.02e-10

Immunoglobulin V-Type;


Pssm-ID: 214650  Cd Length: 81  Bit Score: 55.85  E-value: 3.02e-10
                           10        20        30        40        50        60        70
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 308522730    48 TLRCHLSPEKNAeDMEVRWFR-SQFSPAVFVYKGGRERTEEQMEEYRGRTTFvSKDISRGSVALVIHNITAQENGTYRC 125
Cdd:smart00406   3 TLSCKFSGSTFS-SYYVSWVRqPPGKGLEWLGYIGSNGSSYYQESYKGRFTI-SKDTSKNDVSLTISNLRVEDTGTYYC 79
IgV_HHLA2 cd16091
Immunoglobulin Variable (IgV) domain in HERV-H LTR-associating 2 (HHLA2); The members here are ...
38-142 1.24e-09

Immunoglobulin Variable (IgV) domain in HERV-H LTR-associating 2 (HHLA2); The members here are composed of the immunoglobulin variable (IgV) region in HERV-H LTR-associating 2 (HHLA2; also known as B7-H7/B7 homolog 7). HHLA2 is a member of the B7 family of immune regulatory proteins. Mature human HHLA2 consists of an extracellular domain (ECD) with three immunoglobulin-like domains, a transmembrane segment, and a cytoplasmic domain. HHLA2 is widely expressed in human cancers including non-small cell lung carcinoma (NSCLS), triple negative breast cancer (TNBC), and melanoma, but has limited expression on normal tissues. Interestingly, unlike other members of B7 family, HHLA2 is not expressed in mice or rats. HHLA2 functions as a T cell coinhibitory molecules as it inhibits the proliferation of activated CD4(+) and CD8(+) T cells and their cytokine production. Furthermore, HHLA2 is constitutively expressed on the surface of human monocytes and is induced on B cells after stimulation, however it is not inducible on T cells.


Pssm-ID: 409512  Cd Length: 107  Bit Score: 55.09  E-value: 1.24e-09
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 308522730  38 PILATVGENTTLRCHLSPeknAEDMEVRWFRSQFSPAVFVYKGGRERTEEQMEEYRGRTTFVSKDISRGSVALVIHNITA 117
Cdd:cd16091    6 IVVCLLSEDCILPCSFTP---GSEVVIHWYKQDSDIKVHSYYYGKDQLESQDQRYRNRTSLFKDQISNGNASLLLRRVQL 82
                         90       100
                 ....*....|....*....|....*
gi 308522730 118 QENGTYRCYFQEGRSYDEAILHLVV 142
Cdd:cd16091   83 QDEGRYKCYTSTIIGNQESFVNLKV 107
IgV_SIRP cd16097
Immunoglobulin (Ig)-like variable (V) domain of the Signal-Regulatory Protein (SIRP); The ...
32-134 9.91e-07

Immunoglobulin (Ig)-like variable (V) domain of the Signal-Regulatory Protein (SIRP); The members here are composed of the immunoglobulin (Ig)-like domain of the Signal-Regulatory Protein (SIRP). The SIRPs belong to the "paired receptors" class of membrane proteins that comprise several genes coding for proteins with similar extracellular regions, but very different transmembrane/cytoplasmic regions with different (activating or inhibitory) signaling potentials. They are commonly on NK cells, but are also on many myeloid cells. Their extracellular region contains three immunoglobulin superfamily domains, a single V-set, and two C1-set IgSF domains. Their cytoplasmic tails that contain either ITIMs or transmembrane regions have positively charged residues that allow an association with adaptor proteins, such as DAP12/KARAP, containing ITAMs. There are 3 distinct SIRP members: alpha, beta, and gamma. SIRP alpha (also known as CD172a or SRC homology 2 domain-containing protein tyrosine phosphatase substrate 1/Shps-1) is a membrane receptor that interacts with a ligand CD47 expressed on many cells and gives an inhibitory signal through immunoreceptor tyrosine-based inhibition motifs in the cytoplasmic region that interact with phosphatases SHP-1 and SHP-2. SIRP beta has a short cytoplasmic region and associates with a transmembrane adapter protein DAP12 containing immunoreceptor tyrosine-based activation motifs to give an activating signal. SIRP gamma contains a very short cytoplasmic region lacking obvious signaling motifs, but also binds CD47 with much less affinity. Members of this group contain standard Ig superfamily V-set AGFCC'C"/DEB domain topology.


Pssm-ID: 409516  Cd Length: 111  Bit Score: 46.78  E-value: 9.91e-07
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 308522730  32 VVGPTDPILATVGENTTLRCHLS------PeknaedmeVRWFRSQfSPavfvykgGRERTEEQMEEYRGRTTFVSKDISR 105
Cdd:cd16097    2 VIQPEKSVSVAAGESATLHCTVTslipvgP--------IQWFRGA-GP-------GRELIYNQKEGHFPRVTTVSDLTKR 65
                         90       100       110
                 ....*....|....*....|....*....|..
gi 308522730 106 GSVALVIH--NITAQENGTYRCY-FQEGRSYD 134
Cdd:cd16097   66 NNMDFSIRisNITPADAGTYYCVkFRKGSPDD 97
Ig_CSPGs_LP_like cd05714
Immunoglobulin (Ig)-like domain of chondroitin sulfate proteoglycans (CSPGs), human cartilage ...
33-145 3.09e-06

Immunoglobulin (Ig)-like domain of chondroitin sulfate proteoglycans (CSPGs), human cartilage link protein (LP), and similar domains; The members here are composed of the immunoglobulin (Ig)-like domain similar to that found in chondroitin sulfate proteoglycans (CSPGs) and human cartilage link protein (LP). Included in this group are the CSPGs aggrecan, versican, and neurocan. In CSPGs, this Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, aggrecan forms cartilage link protein stabilized aggregates with hyaluronan (HA). These aggregates contribute to the tissue's load bearing properties. Aggrecan and versican have a wide distribution in connective tissue and extracellular matrices. Neurocan is localized almost exclusively in nervous tissue. Aggregates having other CSPGs substituting for aggrecan may contribute to the structural integrity of many different tissues. There is considerable evidence that HA-binding CSPGs are involved in developmental processes in the central nervous system. Members of the vertebrate HPLN (hyaluronan/HA and proteoglycan binding link) protein family are physically linked adjacent to CSPG genes.


Pssm-ID: 409379  Cd Length: 123  Bit Score: 45.66  E-value: 3.09e-06
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 308522730  33 VGPTDPILATVGENTTLRCHLS-----PEKNAEDMEVRWFRSQFSPA------VFVYKGGRERTEEqmeEYRGRTTFVSK 101
Cdd:cd05714    1 EAESAKVFSHLGGNVTLPCKFYrdptaFGSGIHKIRIKWTKLTSDSGylkevdVLVAMGNVVYHKK---TYGGRVSVPLK 77
                         90       100       110       120
                 ....*....|....*....|....*....|....*....|....
gi 308522730 102 DISRGSVALVIHNITAQENGTYRCYFQEGRSYDEAILHLVVAGL 145
Cdd:cd05714   78 PGSDSDASLVITDLTASDYGLYRCEVIEGIEDDQDVVALDVQGV 121
IgV_CAR_like cd20960
Immunoglobulin Variable (V) domain of the Coxsackievirus and Adenovirus Receptor (CAR), and ...
43-141 4.17e-06

Immunoglobulin Variable (V) domain of the Coxsackievirus and Adenovirus Receptor (CAR), and similar proteins; The members here are composed of the Variable (V) domain of the Coxsackievirus and Adenovirus Receptor (CAR), and similar proteins. CAR, which is encoded by human CXADR gene, is a cell adhesion molecule of the Immunoglobulin (Ig) superfamily. The CAR acts as a type I membrane receptor for group B1-B6 coxsackie viruses and subgroup C adenoviruses. For instance, adenovirus interacts with the coxsackievirus and adenovirus receptor to enter epithelial airway cells. The CAR is also shown to be involved in physiological processes such as neuronal and heart development, epithelial tight junction integrity, and tumor suppression. The CAR is a component of the epithelial apical junction complex that may function as a homophilic cell adhesion molecule and is essential for tight junction integrity. The CAR is also involved in transepithelial migration of leukocytes through adhesive interactions with JAML a transmembrane protein of the plasma membrane of leukocytes. The interaction between both receptors also mediates the activation of gamma-delta T-cells, a subpopulation of T-cells residing in epithelia and involved in tissue homeostasis and repair. The CAR is composed of one V-set and one C2-set Ig module, a single transmembrane helix, and an intracellular domain. This group belongs to the V-set of IgSF domains, having A, B, E and D strands in one beta-sheet and A', G, F, C, C' and C" in the other


Pssm-ID: 409552  Cd Length: 114  Bit Score: 45.13  E-value: 4.17e-06
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 308522730  43 VGENTTLRCHLS---PEKNAEDMEvrWFrsqFSPA------VFVYKGGRERTEEQmEEYRGRTTFVSKDISrGSVALVIH 113
Cdd:cd20960   14 AGENVTLPCHHQlglEDQGTLDIE--WL---LLPSdkvekvVITYSGDRVYNHYY-PALKGRVAFTSNDLS-GDASLNIS 86
                         90       100
                 ....*....|....*....|....*...
gi 308522730 114 NITAQENGTYRCYFQEGRSYDEAILHLV 141
Cdd:cd20960   87 NLKLSDTGTYQCKVKKAPGYAWSKITLI 114
Ig_LP_like cd05877
Immunoglobulin (Ig)-like domain of human cartilage link protein (LP), and similar domains; The ...
35-144 7.13e-06

Immunoglobulin (Ig)-like domain of human cartilage link protein (LP), and similar domains; The members here are composed of the immunoglobulin (Ig)-like domain similar to that found in human cartilage link protein (LP; also called hyaluronan and proteoglycan link protein). In cartilage, chondroitin-keratan sulfate proteoglycan (CSPG), aggrecan, forms cartilage link protein stabilized aggregates with hyaluronan (HA). These aggregates contribute to the tissue's load bearing properties. Aggregates having other CSPGs substituting for aggrecan may contribute to the structural integrity of many different tissues. Members of the vertebrate HPLN (hyaluronan/HA and proteoglycan binding link) protein family are physically linked adjacent to CSPG genes.


Pssm-ID: 409461  Cd Length: 117  Bit Score: 44.62  E-value: 7.13e-06
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 308522730  35 PTDPILATVGENTTLRCHLSPEKNAED---MEVRWFRSQFSPA----VFVYKGGRERTeeqMEEYRGRTTFVSKDisRGS 107
Cdd:cd05877    3 VQAKVFSHRGGNVTLPCRYHYEPELSAprkIRVKWTKLEVDYAkeedVLVAIGTRHKS---YGSYQGRVFLRRAD--DLD 77
                         90       100       110
                 ....*....|....*....|....*....|....*..
gi 308522730 108 VALVIHNITAQENGTYRCYFQEGRSYDEAILHLVVAG 144
Cdd:cd05877   78 ASLVITDLRLEDYGRYRCEVIDGLEDESVVVALRLRG 114
IG_like smart00410
Immunoglobulin like; IG domains that cannot be classified into one of IGv1, IGc1, IGc2, IG.
38-142 9.75e-06

Immunoglobulin like; IG domains that cannot be classified into one of IGv1, IGc1, IGc2, IG.


Pssm-ID: 214653 [Multi-domain]  Cd Length: 85  Bit Score: 43.26  E-value: 9.75e-06
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 308522730    38 PILATVGENTTLRCHLSPEKNAEdmeVRWFRSQFSPAVfvykggrerteeqmeeYRGRTTFVSkdiSRGSVALVIHNITA 117
Cdd:smart00410   3 SVTVKEGESVTLSCEASGSPPPE---VTWYKQGGKLLA----------------ESGRFSVSR---SGSTSTLTISNVTP 60
                           90       100
                   ....*....|....*....|....*
gi 308522730   118 QENGTYRCYFQEGRSYDEAILHLVV 142
Cdd:smart00410  61 EDSGTYTCAATNSSGSASSGTTLTV 85
IgV_PDl1 cd20947
Immunoglobulin Variable (IgV) domain of Programmed death ligand 1 (PD-L1); The members here ...
32-130 1.33e-05

Immunoglobulin Variable (IgV) domain of Programmed death ligand 1 (PD-L1); The members here are composed of the immunoglobulin variable (IgV) domain of Programmed death ligand 1 (PD-L1; also known as Cluster of Differentiation 274 (CD274)). PD-L1 is a cell-surface ligand that competes with PD-L2 for binding to the immunosuppressive receptor programmed death-1 (PD-1). PD-1 is a member of the B7 family that plays an important role in negatively regulating immune responses upon interaction with its two ligands, PD-L1 or PD-L2. Like PD-L2, PD-L1 interacts with PD-1 and suppresses T cell proliferation and cytokine production. The PD-1 receptor is expressed on the surface of activated T cells, while PD-L1 is expressed on cancer cells. When PD-1 and PD-L1 bind together, they form a molecular shield protecting tumor cells from being destroyed by the immune system. Thus, inhibiting the binding of PD-L1 to PD-1 with an antibody leads to killing of tumor cells by T cells. PD-1 inhibitors (such as Pembrolizumab, Nivolumab, and Cemiplimab) and PD-L1 inhibitors (such as Atezolizumab, Avelumab, and Durvalumab ) are an emerging class of immunotherapy that stimulate lymphocytes against tumor cells.


Pssm-ID: 409539  Cd Length: 110  Bit Score: 43.77  E-value: 1.33e-05
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 308522730  32 VVGPTDPILATVGENTTLRCHLSPEK--NAEDMEVRWFRSQFSPAVFVYkgGRERTEEQMEEYRGRTTFVSKDISRGSVA 109
Cdd:cd20947    1 VTVPKDLYVVEYGSNMTIECKFPVEKqlDLAALIVYWEMEDKNIIQFVH--GEEDLKVQHSSYRQRARLLKDQLSLGNAA 78
                         90       100
                 ....*....|....*....|.
gi 308522730 110 LVIHNITAQENGTYRCYFQEG 130
Cdd:cd20947   79 LQITDVKLQDAGVYRCMISYG 99
IgV_1_PVR_like cd05718
First immunoglobulin variable (IgV) domain of poliovirus receptor (PVR, also known as CD155 ...
41-127 1.90e-05

First immunoglobulin variable (IgV) domain of poliovirus receptor (PVR, also known as CD155 and necl-5), and similar domains; The members here are composed of the first immunoglobulin (Ig) domain of poliovirus receptor (PVR, also known as CD155 and nectin-like protein 5 (necl-5)). Poliovirus (PV) binds to its cellular receptor (PVR/CD155) to initiate infection. CD155 is a membrane-anchored, single-span glycoprotein; its extracellular region has three Ig-like domains. There are four different isotypes of CD155 (referred to as alpha, beta, gamma, and delta), that result from alternate splicing of the CD155 mRNA, and have identical extracellular domains. CD155-beta and CD155-gamma are secreted; CD155-alpha and CD155-delta are membrane-bound and function as PV receptors. The virus recognition site is contained in the amino-terminal domain, D1. Having the virus attachment site on the receptor distal from the plasma membrane may be important for successful initiation of infection of cells by the virus. CD155 binds in the poliovirus "canyon" with a footprint similar to that of the intercellular adhesion molecule-1 receptor on human rhinoviruses. This group also includes the first Ig-like domain of nectin-1 (also known as poliovirus receptor related protein(PVRL)1; CD111), nectin-3 (also known as PVRL 3), nectin-4 (also known as PVRL4; LNIR receptor)and DNAX accessory molecule 1 (DNAM-1; CD226).


Pssm-ID: 409383  Cd Length: 113  Bit Score: 43.20  E-value: 1.90e-05
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 308522730  41 ATVGENTTLRCHLSPEKNAEDMEVRWFR----SQFSPAVFVYKGGrertEEQMEEYRGRTTFVSKDISRGSVALVIHNIT 116
Cdd:cd05718   11 GFLGGSVTLPCSLTSPGTTKITQVTWMKigagSSQNVAVFHPQYG----PSVPNPYAERVEFLAARLGLRNATLRIRNLR 86
                         90
                 ....*....|.
gi 308522730 117 AQENGTYRCYF 127
Cdd:cd05718   87 VEDEGNYICEF 97
IgV_CRIg cd16089
Immunoglobulin variable (IgV)-like domain in complement receptor of the immunoglobulin ...
46-125 5.99e-05

Immunoglobulin variable (IgV)-like domain in complement receptor of the immunoglobulin superfamily (CRIg); The members here are composed of the immunoglobulin variable (IgV) region of the complement receptor of the immunoglobulin superfamily (CRIg). The N-terminal domain of CRIg (also known as Z39Ig and V-set and Ig domain-containing 4 (VSIG4) belongs to the IgV family of immunoglobulin-like domains while the C-terminal domain of CRIg belongs to the IgC family of immunoglobulin-like domains. Like all members of this family, the CRIg domain contains two beta-sheets: one composed of strands A', G, F, C, C' and C", and the other of strands B, E and D. The complement system is an important part of the innate immune system and is required for removal of pathogens from the bloodstream. After exposure to pathogens, the third component of the complement system, C3, is cleaved to C3b which, after recruitment of factor B, initiates formation of the alternative pathway convertases. CRIg, a complement receptor expressed on macrophages, binds to C3b and iC3b mediating phagocytosis of the particles. It is also a potent inhibitor of the alternative pathway convertases and a negative regulator of T cell activation. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of this group are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as, T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as, butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.


Pssm-ID: 409510  Cd Length: 117  Bit Score: 41.74  E-value: 5.99e-05
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 308522730  46 NTTLRCHLSPEKNAEDMEVRWF--RSQFSPAVFVYKGGRERTeeQMEEYRGRTTfVSKDISrGSVALVIHNITAQENGTY 123
Cdd:cd16089   16 SVNLPCTYVPEEGYTQVLVKWLvqRDSDPVTIFLRDSSGDHI--QQAKYRGRLE-VSKDTP-GDVSLQLDTLEMDDRGHY 91

                 ..
gi 308522730 124 RC 125
Cdd:cd16089   92 TC 93
Ig_Aggrecan_like cd05878
Immunoglobulin (Ig)-like domain of the aggrecan-like chondroitin sulfate proteoglycan core ...
33-145 2.35e-04

Immunoglobulin (Ig)-like domain of the aggrecan-like chondroitin sulfate proteoglycan core protein (CSPG); The members here are composed of the immunoglobulin (Ig)-like domain of the aggrecan-like chondroitin sulfate proteoglycan core proteins (CSPGs). Included in this group are the Ig domains of other CSPGs: versican, and neurocan. In CSPGs, this Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, aggrecan forms cartilage link protein stabilized aggregates with hyaluronan (HA). These aggregates contribute to the tissue's load bearing properties. Aggrecan and versican have a wide distribution in connective tissue and extracellular matrices. Neurocan is localized almost exclusively in nervous tissue. Aggregates having other CSPGs substituting for aggrecan may contribute to the structural integrity of many different tissues. Members of the vertebrate HPLN (hyaluronan/HA and proteoglycan binding link) protein family are physically linked adjacent to CSPG genes.


Pssm-ID: 409462  Cd Length: 125  Bit Score: 40.29  E-value: 2.35e-04
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 308522730  33 VGPTDPILATVGENTTLRCHLS------PEKNAED-MEVRWFRSQFSPA------VFVYKGGRERTEEqmeEYRGRTTFV 99
Cdd:cd05878    1 IPQSSPVRVLLGTSVTLPCYFIdpphpvTPSTAPLaPRIKWSKVSVDGKkekevvLLVATEGRVRVNS---AYQGRVSLP 77
                         90       100       110       120
                 ....*....|....*....|....*....|....*....|....*.
gi 308522730 100 SKDISRGSVALVIHNITAQENGTYRCYFQEGRSYDEAILHLVVAGL 145
Cdd:cd05878   78 NYPAIPSDATLEVQSLRASDSGLYRCEVMHGIEDSQDTVELVVKGV 123
IgV_P0 cd05879
Immunoglobulin (Ig)-like domain of protein zero (P0); The members here are composed of the ...
31-125 3.22e-04

Immunoglobulin (Ig)-like domain of protein zero (P0); The members here are composed of the immunoglobulin (Ig) domain of protein zero (P0), a myelin membrane adhesion molecule. P0 accounts for over 50% of the total protein in peripheral nervous system (PNS) myelin. P0 is a single-pass transmembrane glycoprotein with a highly basic intracellular domain and an Ig domain. The extracellular domain of P0 (P0-ED) is similar to the Ig variable domain, carrying one acceptor sequence for N-linked glycosylation. P0 plays a role in membrane adhesion in the spiral wraps of the myelin sheath. The intracellular domain is thought to mediate membrane apposition of the cytoplasmic faces and may, through electrostatic interactions, interact directly with lipid headgroups. It is thought that homophilic interactions of the P0 extracellular domain mediate membrane juxtaposition in the extracellular space of PNS myelin.


Pssm-ID: 409463  Cd Length: 117  Bit Score: 39.86  E-value: 3.22e-04
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 308522730  31 IVVGPTDPILATVGENTTLRCHL-SPEKNAEDMEVRW-FR---SQFSPAVFVYKGGRERTEEqMEEYRGRTTFVSkDISR 105
Cdd:cd05879    1 IVVYTDREVYGTVGSDVTLSCSFwSSEWISDDISFTWhYQpdgSRDAISIFHYGKGQPYIDN-VGPFKERIEWVG-NPSR 78
                         90       100
                 ....*....|....*....|
gi 308522730 106 GSVALVIHNITAQENGTYRC 125
Cdd:cd05879   79 KDGSIVIHNLDYTDNGTFTC 98
IgV_CD2_like_N cd05775
N-terminal immunoglobulin (Ig)-like domain of T-cell surface antigen CD2, and similar domains; ...
39-124 6.29e-04

N-terminal immunoglobulin (Ig)-like domain of T-cell surface antigen CD2, and similar domains; The members here are composed of the N-terminal immunoglobulin (Ig)-like domain (or domain 1) of T-cell surface antigen Clusters of Differentiation (CD) 2 and similar proteins. CD2 is a T-cell specific surface glycoprotein and is critically important for mediating adhesion between T cells and antigen-presenting cells or between cytolytic T cells and target cells. CD2 is located on chromosome 1 at 1p13 in humans and on chromosome 3 in mice. CD2 contains an extracellular domain with two or Ig-like domains, a single transmembrane segment, and a cytoplasmic region rich in proline and basic residues.


Pssm-ID: 409431  Cd Length: 98  Bit Score: 38.48  E-value: 6.29e-04
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 308522730  39 ILATVGENTTLRchlSPEKNAEDMEVRWFRSQFSPAVFVYKGGrertEEQMEEYRGRTTFvskDISRGSvaLVIHNITAQ 118
Cdd:cd05775    5 VYGALGGNVTLT---ISSLQDDIDEIKWKKTKDKIVEWENNIG----PTYFGSFKDRVLL---DKESGS--LTIKNLTKE 72

                 ....*.
gi 308522730 119 ENGTYR 124
Cdd:cd05775   73 DSGTYE 78
PRK12704 PRK12704
phosphodiesterase; Provisional
251-322 2.77e-03

phosphodiesterase; Provisional


Pssm-ID: 237177 [Multi-domain]  Cd Length: 520  Bit Score: 39.38  E-value: 2.77e-03
                         10        20        30        40        50        60        70
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 308522730 251 LPIIVVILMIPIAVCI-YWINKLQKEKKILSGEKEFER--ETREIALKELEKERV--QKEEELQVKEKLQEELRWRR 322
Cdd:PRK12704   5 IIILIALVALVVGAVIgYFVRKKIAEAKIKEAEEEAKRilEEAKKEAEAIKKEALleAKEEIHKLRNEFEKELRERR 81
IgV_TIM-3_like cd20982
Immunoglobulin Variable (IgV) domain of T cell Immunoglobulin Domain and Mucin Domain 3 (Tim-3) ...
41-128 2.85e-03

Immunoglobulin Variable (IgV) domain of T cell Immunoglobulin Domain and Mucin Domain 3 (Tim-3), and similar domains; The members here are composed of the immunoglobulin variable (IgV) domain of T cell immunoglobulin domain and mucin domain 3 (Tim-3; also known as Hepatitis A virus cellular receptor 2 (HAVcr-2) and Cluster of Differentiation 366 (CD366)) and similar proteins. TIM-3 is a checkpoint inhibitor in immune responses to tumors, as well as involved in chronic viral infections. Thus, Tim-3 has emerged as one of most promising immune checkpoint targets for cancer immunotherapy. Tim-3 is highly expressed on Th1 lymphocytes and CD11b(+) macrophages and is upregulated on activated T and myeloid cells. TIM-3 regulates macrophage, activation and inhibits Th1 mediated immune responses to promote immunological tolerance. There are three TIM family members in humans (TIM-1, TIM-3, and TIM-4) and eight members in mice (TIM-1 to TIM-8). The IgV domain of human TIM-3 has been shown to bind ligands such as carcinoembryonic antigen cell adhesion molecule 1 (CEACAM1), high mobility group protein B1 (HMGB1)and galectin-9 (GAL9). The binding of GAL9 to TIM-3 can negatively regulate Th1 immune response, enhance immune tolerance and inhibit anti#tumor immunity. Dysregulation of the TIM-3/GAL9 pathway is implicated in numerous chronic autoimmune diseases, such as multiple sclerosis and systemic lupus erythematosus.


Pssm-ID: 409574  Cd Length: 107  Bit Score: 36.67  E-value: 2.85e-03
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 308522730  41 ATVGENTTLRCHLSPEKNAEDMEVRWFRSqFSPavfVYKGGRE--RTEEQMEEYRGRTTFVSK-DISRGSVALVIHNITA 117
Cdd:cd20982    5 AEVGHNAYLPCSYTTAAPGNLVPVCWGKG-ACP---VSYCGNVllRTDERDVTYQKSSRYQLKgDFSKGDVSLTIENVTL 80
                         90
                 ....*....|.
gi 308522730 118 QENGTYRCYFQ 128
Cdd:cd20982   81 ADSGIYCCRIQ 91
Ig_3 pfam13927
Immunoglobulin domain; This family contains immunoglobulin-like domains.
32-125 3.47e-03

Immunoglobulin domain; This family contains immunoglobulin-like domains.


Pssm-ID: 464046 [Multi-domain]  Cd Length: 78  Bit Score: 36.00  E-value: 3.47e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 308522730   32 VVGPTDPILATVGENTTLRCHLS--PEknaedMEVRWfrsqfspavfvYKGGRERTEeqmeeyrGRTTFVSKDISRGSva 109
Cdd:pfam13927   4 ITVSPSSVTVREGETVTLTCEATgsPP-----PTITW-----------YKNGEPISS-------GSTRSRSLSGSNST-- 58
                          90
                  ....*....|....*.
gi 308522730  110 LVIHNITAQENGTYRC 125
Cdd:pfam13927  59 LTISNVTRSDAGTYTC 74
IgV_B7-H2 cd20935
Immunoglobulin Variable (IgV) domain of B7-H2 (B7 homolog 2); The members here are composed of ...
41-125 7.89e-03

Immunoglobulin Variable (IgV) domain of B7-H2 (B7 homolog 2); The members here are composed of the immunoglobulin variable (IgV) domain of B7-H2 (B7 homolog 2 also known as ICOSL (inducible T cell costimulator ligand) or CD275). B7-H2 is a ligand for the T-cell-specific cell surface receptor ICOS and acts as a costimulatory signal for T-cell proliferation and cytokine secretion. The interaction of ICOS with ICOSL (B7-H2) regulates T cell activation and expansion, is involved in T cell dependent B cell activation, and T-helper cell differentiation. It is a member of the B7 family of immune regulatory proteins and shares homology with other B7 ligands, such as B7-1, B7-2, B7-H1 (PD-L1), PD-L2, and B7-H3. The extracellular domains of B7 proteins contain two Ig-like domains and all members have short cytoplasmic domains. These ligands are typically expressed on antigen presenting cells (such as macrophages, B cells and dendritic cells) and have the ability to regulate T-cell proliferation and function. Tumor cells are also capable of expressing the B7 family members in order to evade immune surveillance.


Pssm-ID: 409529  Cd Length: 113  Bit Score: 35.61  E-value: 7.89e-03
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 308522730  41 ATVGENTTLRChLSPEKNA---EDMEVRWFRSQFSPAVFVYKGGRERTEEQMEEYRGRTTFVSKDISRGSVALVIHNITA 117
Cdd:cd20935    5 AMVGSDVELSC-ICPEGSRfdlNDLYVYWQISESETVVTYHLPQNSSLENVDSHYRNRALLSLDSMKQGDFSLRLFNVTP 83

                 ....*...
gi 308522730 118 QENGTYRC 125
Cdd:cd20935   84 QDEQKFHC 91
PilN COG3166
Type IV pilus assembly protein PilN [Cell motility, Extracellular structures];
249-317 9.85e-03

Type IV pilus assembly protein PilN [Cell motility, Extracellular structures];


Pssm-ID: 442399 [Multi-domain]  Cd Length: 185  Bit Score: 36.48  E-value: 9.85e-03
                         10        20        30        40        50        60        70
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 308522730 249 VALPIIVVILMIPIAVCIYW-----INKLQKEKKILSGE-KEFERETREIalKELEKERVQKEEELQVKEKLQEE 317
Cdd:COG3166   22 LALLVLALLLALAVLFLVYLylqgqIAQQQARNAALQQEiAKLDKQIAEI--KELKKQKAELLARLQVIEQLQQS 94
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH